These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5526209)

  • 1. [Pharmacologic viewpoint on so-called coronary dilator drugs].
    Faucon G; Evreux JC; Bazaugour R
    Therapie; 1970; 25(2):275-92. PubMed ID: 5526209
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various aspects of the pharmacology of iproveratril, a new synthetic coronary dilator with anti-arrhythmic value].
    Melville KI; Shister HE; Mignault Jde L; Garvey L
    Union Med Can; 1969 Apr; 98(4):592-6. PubMed ID: 5355792
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcium antagonism as a mode of action of coronary vasodilator agents].
    Meisel P; Rohde M; Rönfanz M; Teichmann H; Fermum R
    Pharmazie; 1976 Jul; 31(7):417-31. PubMed ID: 790400
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symposium on problems in the clinical pharmacology of coronary dilators. Introduction].
    Holtz P
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):121-7. PubMed ID: 4308585
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influencing of oxygen pressure in the myocardium by coronary dilators].
    Kadatz R; Diederen W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):156-9. PubMed ID: 5804228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coronary vasodilator agents].
    Nakamura Y
    Kokyu To Junkan; 1974 Sep; 22(9):662. PubMed ID: 4475463
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of coronary vasodilators on cornary blood flow in man.
    Hilger HH
    Brux Med; 1970 Sep; 50(9):557-65. PubMed ID: 5510355
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolic effects of various palliative drugs for coronary insufficiency].
    Deltour G
    Therapie; 1970; 25(2):293-322. PubMed ID: 4404034
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacologic bases of antiangina properties of amiodarone].
    Charlier R
    Brux Med; 1970 Sep; 50(9):651-6. PubMed ID: 5510367
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacologic aspects of reactions of the cardiac circulation to drugs].
    Zakusov VV
    Vestn Akad Med Nauk SSSR; 1963; 18(1):3-9. PubMed ID: 5889334
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacology and clinical effects of lidoflazine].
    Janssen PA
    Actual Pharmacol (Paris); 1970; 23():135-61. PubMed ID: 4948983
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sympatholytic ("antisympathotonic") substances].
    Kruger K
    Minerva Med; 1968 Dec; 59(96):5227-30. PubMed ID: 5710726
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chromotropic, inotropic and coronary dilator actions of some heptaminol derivatives].
    Duchêne-Marullaz P; Cosnier D; Szabo S; Mollat F
    Therapie; 1968; 23(2):383-97. PubMed ID: 5701513
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of trinitrin on coronary flow].
    Warembourg H; Houdas Y; Bertrand M; Ketelers JY
    Lille Med; 1969; 14(4):377-82. PubMed ID: 4978294
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacology of coronary dilators].
    Hashimoto K
    Saishin Igaku; 1970 Jan; 25(1):120-5. PubMed ID: 5445204
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of pharmacologic agents on the blood supply of the heart in acute coronary circulatory disorders].
    Markova GA
    Vestn Akad Med Nauk SSSR; 1963; 18(1):33-5. PubMed ID: 4971962
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of flavon-7-ethyl oxyacetate on the cardiovascular system].
    Takenaka F; Takeya N; Tazume Y; Hayakawa T; Sakai M
    Kumamoto Igakkai Zasshi; 1967 Sep; 41(9):843-8. PubMed ID: 5631463
    [No Abstract]   [Full Text] [Related]  

  • 18. [Site of action of the coronary drug carbocromen].
    Alfes H; Schraven E; Möllmann H; Ostrowski J; Bigalke G; Nitz RE
    Fortschr Med; 1973 Jul; 91(19):837-43. PubMed ID: 4198875
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drugs for the management of chronic ischemic heart disease].
    Klotzbach M
    Pharmazie; 1979 Aug; 34(8):487-90. PubMed ID: 43982
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of PGI2 in patients with ischemic heart disease--coronary dilator action of prostacyclin and dissolution of coronary spasms observed in coronary angiography].
    Saito S; Tsuzi M; Tamura Y; Tomobe K; Tokutake E; Yumikura S; Hibiya K; Yamamoto M; Ichikawa M; Honda M; Ozawa Y; Hatano M
    Kokyu To Junkan; 1982 Oct; 30(10):1033-8. PubMed ID: 6760309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.